President-elect Joe Biden’s goal of administering 100 million coronavirus vaccine shots in his first 100 days is doable, although there could be some issues of demand, former Food and Drug Administration commissioner Dr. Scott Gottlieb told CBS News’ “Face the Nation” on Sunday.
“I think they will hit that 100 million mark, I think the issue is going to become demand,” said Gottlieb, who is a member of the board of Pfizer, the drug company which developed one of two coronavirus vaccines currently approved for use in the United States. “I think they're going to have the supply in place and the distribution in place to do that.”
Gottlieb stressed, “I think the plan that the new administration put out makes a lot of sense. It's sort of an all-of-the-above approach, what we've been talking about, trying to push this through different channels like the big-box stores, like pharmacies, trying to set up more federally chartered sites in conjunction with the states."
He added that "I think the federal plan that the Biden administration is modeling builds off what some states that have done well."
Gottlieb warned, however, that the situation is going to get worse before it gets better, citing “a relentless strike from this virus heading into the spring.”
He added that "we need to be honest with ourselves that these strains are here right now, and we need to start taking action," emphasizing that "the quality of the masks really matters right now. If you wear a higher quality mask with this new infection, that's going to be very important."
Brian Freeman ✉
Brian Freeman, a Newsmax writer based in Israel, has more than three decades writing and editing about culture and politics for newspapers, online and television.
© 2025 Newsmax. All rights reserved.